X-ray repair cross-complementing gene I protein plays an important role in camptothecin resistance

Cancer Research

Volumn 62, Issue 2, 2002, Pages 459-465

  Park, Shin Young ^a   Lam, Wing ^a   Cheng, Yung Chi ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CISPLATIN; DNA DIRECTED DNA POLYMERASE BETA; ETOPOSIDE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING GENE I PROTEIN;

ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; EXCISION REPAIR; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; REVERTANT; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CISPLATIN; DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ETOPOSIDE; HUMANS; KB CELLS; POLY(ADP-RIBOSE) POLYMERASES; TOPOTECAN; TRANSFECTION;

EID: 0037081269     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
2. DNA topoisomerase poisons as antitumor drugs
3. DNA topoisomerases as anticancer drug targets
4. Mechanism of action of eukaryotic DNA topoisomerase 1 and drugs targeted to the enzyme
5. Mechanism of action of camptothecin
6. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin
7. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA
8. Cellular resistance to topoisomerase-targeted drugs: From drug uptake to cell death
9. Camptothecin resistance involving steps subsequently to the formation of protein linked DNA breaks in human camptothecin-resistant KB cell lines
10. Topoisomerase I-mediated DNA damage
11. Yeast gene for a tyr-DNA phosphodiesterase that repairs topoisomerase I complexes
12. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin
13. Sumo-I conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage
14. Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair
15. Mechanisms for the processing of a frozen topoisomerase-DNA conjugate by human cell-free extracts
16. The CHO XRCC1 mutant, EM9, deficient in DNA ligase III activity, exhibits hypersensitivity to camptothecin independent of DNA replication
17. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro
18. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange
19. XRCC1 keeps DNA from getting stranded
20. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III
21. Characterization of the XRCC1-DNA ligase III complex in vitro and its absence from mutant hamster cells
22. XRCC1 protein interacts with one of two distinct forms of DNA ligase III
23. Reconstitution of DNA base excision-repair with purified human proteins: Interaction between DNA polymerase β and the XRCC1 protein
24. XRCC1 polypeptide interacts with DNA polymerase β and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro
25. XRCC1 is specifically associated with poly (ADP-ribose) polymerase and negatively regulates its activity following DNA damage
26. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair
27. ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells
28. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I
29. Characterization of camptothecin-resistant Chinese hamster lung cells
30. Development of a stable camptothecinresistant subline of P388 leukemia with reduced topoisomerase I content
31. Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase 1
32. Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin
33. A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase 1
34. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line
35. Poly (ADP-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability
36. Poly (ADP-ribose) binds to specific domains in DNA damage checkpoint proteins
37. Quality control by DNA repair
38. Adaptive amplification: An inducible chromosomal instability mechanism
39. Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines
40. Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines
41. Reversal of acquired cisplatin resistance by nicotinamide in vitro and in vivo